Delivery Order SPE2DE24DA017-SPE2D625F3ZNZ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $9,246.60 from the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The order covers APOLLO RF I90 Aspirating Ablator 90 products, with a fixed-price pricing structure that includes economic price adjustment provisions. This delivery order is issued under Arthrex's broader Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $2,438.27 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. The award, identified as contract number 4568978658, is for APOLLO RF I90 Aspirating Ablator 90 and utilizes a fixed-price contract type with economic price adjustment provisions. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (IDC...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $7,012.44 from the Defense Logistics Agency's Medical Supply Chain on August 14, 2025, for APOLLO RF I90 aspirating ablator 90 products. This fixed-price delivery order with economic price adjustment falls under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a comprehensive $471 million agreement running...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $3,363.36 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. The contract, identified as APOLLO RF I90 Aspirating Ablator 90, is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 28, 2025. This award was issued without set-aside designation,...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, received a $4,394.84 delivery order for APOLLO RF I90 Aspirating Ablator 90 from the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. This fixed-price delivery order with economic price adjustment is scheduled for completion by July 3, 2025, and represents a non-set-aside award. The product will be delivered to Naples, Florida, supporting the federal government's orthopedic medical...
- Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $6,287.16 for APOLLO RF I90 Aspirating Ablator 90 by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment was executed on August 25, 2025, with an ultimate completion date of August 28, 2025, and does not utilize any set-aside designation. The delivery order will be fulfilled at...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $1,073.17 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The delivery order, which is expected to be completed by August 26, 2025, is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1,...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a delivery order valued at $2,103.12 from the Defense Logistics Agency's Medical Supply Chain on June 5, 2025, for the APOLLO RF I90 Aspirating Ablator 90. This fixed-price delivery order with economic price adjustment is scheduled for completion by June 10, 2025, and will be performed at the company's Naples, Florida location. The award represents no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies based in Naples, Florida, was awarded a delivery order valued at $1,552.32 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025, with an ultimate completion date of September 16, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, covers the supply of Apollo RF I90 Aspirating Ablator 90 products. This award was issued without a...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $8,368.64 from the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. The award, designated as a fixed-price contract with economic price adjustment, calls for delivery of APOLLO RF I90 Aspirating Ablator 90 products. The contract is not set aside for any specific business type and carries an ultimate completion date of August...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F3ZNZDelivery Order
Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order valued at $1,293.60 for APOLLO RF I90 Aspirating Ablator 90 from the Defense Logistics Agency's Medical Supply Chain on September 22, 2025. This fixed-price delivery order with economic price adjustment represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The work is to be performed in Naples, Florida, with an ultimate completion date of September 25, 2025. This delivery order supports the Defense Logistics Agency's mission to supply advanced orthopedic surgical technologies to Department of Veterans Affairs medical centers and Department of Defense healthcare systems nationwide. Arthrex has demonstrated substantial capability under its primary IDC, having received over $550,000 in delivery orders to date. The company's portfolio includes surgical implants, arthroscopic instruments, joint replacement systems, suture anchors, and specialized surgical kits designed to support orthopedic procedures for military personnel and veterans requiring advanced minimally invasive treatment options.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/22/25 |